Last updated on November 2017

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).


Brief description of study

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

Detailed Study Description

24-Week trial comparing treatment with Study Medicine vs. placebo.

Patient Inclusion Criteria:

  • Age >/= 18
  • Diagnosis of definite AS
  • Active AS
  • Inadequate response to treatment.

Patient Exclusion Criteria:

  • Major Surgery within 8 weeks prior to screening
  • Inflammatory Disease other than AS
  • Treatment with Investigational Medication within 4 weeks
  • Hepatitis B, C, or HIV

Clinical Study Identifier: TX981

Contact Investigators or Research Sites near you

Start Over

CSI Research Inc

Alpharetta, GA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.